SCHEMBL9073544

SCHEMBL9073544

CC(C)(C)CN1C(C)(C)CCCC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25062990 0.79
SCHEMBL25062253 0.73 EPHX1 (0.32)
SCHEMBL277498 0.73 TSHR (0.33)
SCHEMBL10170023 0.73 TSHR (0.38)
SCHEMBL9972725 0.72 KDM4E (0.38)
SCHEMBL13602670 0.72
SCHEMBL9281510 0.71
SCHEMBL1555233 0.70 TSHR (0.32)
SCHEMBL9281240 0.70
SCHEMBL10170322 0.69 TSHR (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230054997-A1 COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS ALS THERAPY DEVELOPMENT INSTITUTE, 2023-02-23 US disclosed
WO-2022216767-A1 MASS TAGS FOR LIPID ANALYSES THE TEXAS A&M UNIVERSITY SYSTEM (US) 2022-10-13 WO disclosed
US-20160046625-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC (US) 2016-02-18 US disclosed
US-20150306086-A1 MODULATING CERTAIN TYROSINE KINASES TESARO, INC. 2015-10-29 US disclosed
US-9115127-B2 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase AMGEN INC. (US) 2015-08-25 US disclosed
US-20130217668-A1 BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE AMGEN INC. (US) 2013-08-22 US disclosed
US-5498679-A Process for producing telechelic, branched and star thermoplastic resin polymers XEROX CORPORATION (US) 1996-03-12 US disclosed